[Federal Register Volume 88, Number 107 (Monday, June 5, 2023)]
[Notices]
[Pages 36584-36585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11857]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Committee on Immunization Practices (ACIP)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the ACIP. The ACIP consists of up 
to 20 experts in fields associated with immunization practices and 
public health, use of vaccines and other immunobiologic agents in 
clinical practice or preventive medicine, clinical or laboratory 
vaccine research, assessment of vaccine efficacy and safety, or have 
knowledge about consumer perspectives and/or social and community 
aspects of immunization programs.

DATES: Nominations for membership on the ACIP must be received no later 
than August 1, 2023. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations must be completed online at https://www.cdc.gov/vaccines/acip/apply-for-membership/index.html.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE, Mailstop H24-8, Atlanta, Georgia 30329-4027. Telephone: (404) 
639-8836; Email: [email protected].

SUPPLEMENTARY INFORMATION: ACIP members are selected by the Secretary 
of the U.S. Department of Health and Human Services to provide advice 
and guidance to the Secretary, the Assistant Secretary for Health, and 
the CDC on the control of vaccine-preventable diseases. The role of the 
ACIP is to provide advice that will lead to a reduction in the 
incidence of vaccine preventable diseases in the United States, and an 
increase in the safe use of vaccines and related biological products. 
The Committee also establishes, reviews, and as appropriate, revises 
the list of vaccines for administration to children eligible to receive 
vaccines through the Vaccines for Children (VFC) Program.
    Nominations are being sought for individuals who have the expertise 
and qualifications necessary to contribute to the accomplishments of 
the committee's objectives. Nominees will be selected based on 
expertise in the fields of immunization practices; multi-disciplinary 
expertise in public health; expertise in the use of vaccines and 
immunologic agents in both clinical and preventive medicine; knowledge 
of vaccine development, evaluation, and vaccine delivery; or knowledge 
about consumer perspectives and/or social and community aspects of 
immunization programs. Members shall be deemed Special Government 
Employees. Federal employees will not be considered for membership. 
Members may be invited to serve for up to four-year terms. Selection of 
members is based on candidates' qualifications to contribute to the 
accomplishment of ACIP objectives (https://www.cdc.gov/vaccines/acip/index.html).
    The U.S. Department of Health and Human Services policy stipulates 
that committee membership be balanced in terms of points of view 
represented, and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees (SGEs), requiring the filing 
of financial disclosure reports at the beginning and annually during 
their terms. CDC reviews potential candidates for ACIP membership each 
year and provides a slate of nominees for consideration to the 
Secretary of HHS for final selection. HHS notifies selected candidates 
of their appointment near the start of the term in July, or as soon as 
the HHS selection process is completed. Note that the need for 
different expertise varies from year to year and a candidate who is not 
selected in one year may be reconsidered in a subsequent year. SGE 
nominees must be U.S. citizens and cannot be full-time employees of the 
U.S. Government. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] Two letters of recommendation from professional colleagues 
familiar with the candidate's work. A maximum of four letters of 
recommendation will be accepted.
    [cir] Letters of recommendation should not come from current ACIP 
members.
    [cir] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted

[[Page 36585]]

by a person not employed by an HHS agency (e.g., NIH, FDA, etc.). CDC 
employees should not provide letters of recommendation.
    [ssquf] A cover letter that includes the candidate's statement of 
interest in serving on the ACIP, the qualifications and expertise that 
the candidate would bring, and written evidence to support how the 
candidate meets all relevant criteria.
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention
[FR Doc. 2023-11857 Filed 6-2-23; 8:45 am]
BILLING CODE 4163-18-P